# TAUKLARIFY
> **NDA220496** · New Drug Application · Sponsor: CERVEAU LANTHEUS · Approved 2026-08-13
## Drug
- **FDA Application Number:** NDA220496
- **Application type:** New Drug Application
- **Brand name:** TAUKLARIFY
- **Generic name:** Florquinitau F-18
- **Active ingredients:** FLORQUINITAU F-18
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CERVEAU LANTHEUS
- **First approval:** 2026-08-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220496)
---
*MORVS · CC0 1.0*